.

Insmed reported 67.02M in Stock for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acelrx Pharmaceuticals ACRX:US $ 0.9M 0.14M
Alimera Sciences ALIM:US $ 1.66M 0.8M
Biomarin Pharmaceutical BMRN:US $ 802.32M 15.96M
Dynavax Technologies DVAX:US $ 73.98M 5.06M
Gilead Sciences GILD:US $ 2587M 88M
Heron Therapeutics HRTX:US $ 61.32M 4.85M
Regeneron Pharmaceuticals REGN:US $ 2218.5M 227M
Sarepta Therapeutics SRPT:US $ 208.1M 9.1M
Seattle Genetics SGEN:US $ 319.35M 43.61M
Ultragenyx Pharmaceutical RARE:US $ 21.08M 3.27M
Vertex Pharmaceuticals VRTX:US $ 367.7M 28.8M